Microfluidic  ||| S:28 E:41 ||| JJ
cell  ||| S:41 E:46 ||| NN
culture  ||| S:46 E:54 ||| NN
integrates  ||| S:54 E:65 ||| NN
knowledge  ||| S:65 E:75 ||| NN
from  ||| S:75 E:80 ||| IN
biology ||| S:80 E:87 ||| NN
,  ||| S:87 E:89 ||| ,
biochemistry ||| S:89 E:101 ||| NN
,  ||| S:101 E:103 ||| ,
engineering ||| S:103 E:114 ||| NN
,  ||| S:114 E:116 ||| ,
and  ||| S:116 E:120 ||| CC
physics  ||| S:120 E:128 ||| NN
to  ||| S:128 E:131 ||| TO
develop  ||| S:131 E:139 ||| VB
devices  ||| S:139 E:147 ||| NNS
and  ||| S:147 E:151 ||| CC
techniques  ||| S:151 E:162 ||| NNS
for  ||| S:162 E:166 ||| IN
culturing ||| S:166 E:175 ||| NN
,  ||| S:175 E:177 ||| ,
maintaining ||| S:177 E:188 ||| VBG
,  ||| S:188 E:190 ||| ,
analyzing ||| S:190 E:199 ||| VBG
,  ||| S:199 E:201 ||| ,
and  ||| S:201 E:205 ||| CC
experimenting  ||| S:205 E:219 ||| VBG
with  ||| S:219 E:224 ||| IN
cells  ||| S:224 E:230 ||| NNS
at  ||| S:230 E:233 ||| IN
the  ||| S:233 E:237 ||| DT
microscale ||| S:237 E:247 ||| NN
.  ||| S:247 E:249 ||| .
It  ||| S:249 E:252 ||| PRP
merges  ||| S:252 E:259 ||| VBP
microfluidics ||| S:259 E:272 ||| VBN
,  ||| S:272 E:274 ||| ,
a  ||| S:274 E:276 ||| DT
set  ||| S:276 E:280 ||| NN
of  ||| S:280 E:283 ||| IN
technologies  ||| S:283 E:296 ||| NNS
used  ||| S:296 E:301 ||| VBN
for  ||| S:301 E:305 ||| IN
the  ||| S:305 E:309 ||| DT
manipulation  ||| S:309 E:322 ||| NN
of  ||| S:322 E:325 ||| IN
small  ||| S:325 E:331 ||| JJ
fluid  ||| S:331 E:337 ||| JJ
volumes  ||| S:337 E:345 ||| NNS
( ||| S:345 E:346 ||| -LRB-
μL ||| S:346 E:348 ||| NNP
,  ||| S:348 E:350 ||| ,
nL ||| S:350 E:352 ||| NNP
,  ||| S:352 E:354 ||| ,
pL ||| S:354 E:356 ||| NNP
)  ||| S:356 E:358 ||| -RRB-
within  ||| S:358 E:365 ||| IN
artificially  ||| S:365 E:378 ||| RB
fabricated  ||| S:378 E:389 ||| JJ
microsystems ||| S:389 E:401 ||| NN
,  ||| S:401 E:403 ||| ,
and  ||| S:403 E:407 ||| CC
cell  ||| S:407 E:412 ||| NN
culture ||| S:412 E:419 ||| NN
,  ||| S:419 E:421 ||| ,
which  ||| S:421 E:427 ||| WDT
involves  ||| S:427 E:436 ||| VBZ
the  ||| S:436 E:440 ||| DT
maintenance  ||| S:440 E:452 ||| NN
and  ||| S:452 E:456 ||| CC
growth  ||| S:456 E:463 ||| NN
of  ||| S:463 E:466 ||| IN
cells  ||| S:466 E:472 ||| NNS
in  ||| S:472 E:475 ||| IN
a  ||| S:475 E:477 ||| DT
controlled  ||| S:477 E:488 ||| JJ
laboratory  ||| S:488 E:499 ||| NN
environment ||| S:499 E:510 ||| NN
.  ||| S:510 E:512 ||| .
Microfluidics  ||| S:512 E:526 ||| NNP
has  ||| S:526 E:530 ||| VBZ
been  ||| S:530 E:535 ||| VBN
used  ||| S:535 E:540 ||| VBN
for  ||| S:540 E:544 ||| IN
cell  ||| S:544 E:549 ||| NN
biology  ||| S:549 E:557 ||| NN
studies  ||| S:557 E:565 ||| NNS
as  ||| S:565 E:568 ||| IN
the  ||| S:568 E:572 ||| DT
dimensions  ||| S:572 E:583 ||| NN
of  ||| S:583 E:586 ||| IN
the  ||| S:586 E:590 ||| DT
microfluidic  ||| S:590 E:603 ||| JJ
channels  ||| S:603 E:612 ||| NNS
are  ||| S:612 E:616 ||| VBP
well  ||| S:616 E:621 ||| RB
suited  ||| S:621 E:628 ||| VBN
for  ||| S:628 E:632 ||| IN
the  ||| S:632 E:636 ||| DT
physical  ||| S:636 E:645 ||| JJ
scale  ||| S:645 E:651 ||| NN
of  ||| S:651 E:654 ||| IN
cells ||| S:654 E:659 ||| NNS
.  ||| S:659 E:661 ||| .
For  ||| S:661 E:665 ||| IN
example ||| S:665 E:672 ||| NN
,  ||| S:672 E:674 ||| ,
eukaryotic  ||| S:674 E:685 ||| JJ
cells  ||| S:685 E:691 ||| NNS
have  ||| S:691 E:696 ||| VBP
linear  ||| S:696 E:703 ||| JJ
dimensions  ||| S:703 E:714 ||| NNS
between  ||| S:714 E:722 ||| IN
10-100  ||| S:722 E:729 ||| CD
μm  ||| S:729 E:732 ||| NNS
which  ||| S:732 E:738 ||| WDT
falls  ||| S:738 E:744 ||| VBZ
within  ||| S:744 E:751 ||| IN
the  ||| S:751 E:755 ||| DT
range  ||| S:755 E:761 ||| NN
of  ||| S:761 E:764 ||| IN
microfluidic  ||| S:764 E:777 ||| JJ
dimensions ||| S:777 E:787 ||| NNS
.  ||| S:787 E:789 ||| .
A  ||| S:789 E:791 ||| DT
key  ||| S:791 E:795 ||| JJ
component  ||| S:795 E:805 ||| NN
of  ||| S:805 E:808 ||| IN
microfluidic  ||| S:808 E:821 ||| JJ
cell  ||| S:821 E:826 ||| NN
culture  ||| S:826 E:834 ||| NN
is  ||| S:834 E:837 ||| VBZ
being  ||| S:837 E:843 ||| VBG
able  ||| S:843 E:848 ||| JJ
to  ||| S:848 E:851 ||| TO
mimic  ||| S:851 E:857 ||| VB
the  ||| S:857 E:861 ||| DT
cell  ||| S:861 E:866 ||| NN
microenvironment  ||| S:866 E:883 ||| NNS
which  ||| S:883 E:889 ||| WDT
includes  ||| S:889 E:898 ||| VBZ
soluble  ||| S:898 E:906 ||| JJ
factors  ||| S:906 E:914 ||| NNS
that  ||| S:914 E:919 ||| IN
regulate  ||| S:919 E:928 ||| JJ
cell  ||| S:928 E:933 ||| NN
structure ||| S:933 E:942 ||| NN
,  ||| S:942 E:944 ||| ,
function ||| S:944 E:952 ||| NN
,  ||| S:952 E:954 ||| ,
behavior ||| S:954 E:962 ||| NN
,  ||| S:962 E:964 ||| ,
and  ||| S:964 E:968 ||| CC
growth ||| S:968 E:974 ||| NN
.  ||| S:974 E:976 ||| .
Another  ||| S:976 E:984 ||| DT
important  ||| S:984 E:994 ||| JJ
component  ||| S:994 E:1004 ||| NN
for  ||| S:1004 E:1008 ||| IN
the  ||| S:1008 E:1012 ||| DT
devices  ||| S:1012 E:1020 ||| NNS
is  ||| S:1020 E:1023 ||| VBZ
the  ||| S:1023 E:1027 ||| DT
ability  ||| S:1027 E:1035 ||| NN
to  ||| S:1035 E:1038 ||| TO
produce  ||| S:1038 E:1046 ||| VB
stable  ||| S:1046 E:1053 ||| JJ
gradients  ||| S:1053 E:1063 ||| NN
that  ||| S:1063 E:1068 ||| WDT
are  ||| S:1068 E:1072 ||| VBP
present  ||| S:1072 E:1080 ||| JJ
"in  ||| S:1080 E:1084 ||| FW
vivo ||| S:1084 E:1088 ||| FW
"  ||| S:1088 E:1090 ||| ''
as  ||| S:1090 E:1093 ||| IN
these  ||| S:1093 E:1099 ||| DT
gradients  ||| S:1099 E:1109 ||| NNS
play  ||| S:1109 E:1114 ||| VBP
a  ||| S:1114 E:1116 ||| DT
significant  ||| S:1116 E:1128 ||| JJ
role  ||| S:1128 E:1133 ||| NN
in  ||| S:1133 E:1136 ||| IN
understanding  ||| S:1136 E:1150 ||| VBG
chemotactic ||| S:1150 E:1161 ||| NN
,  ||| S:1161 E:1163 ||| ,
durotactic ||| S:1163 E:1173 ||| NN
,  ||| S:1173 E:1175 ||| ,
and  ||| S:1175 E:1179 ||| CC
haptotactic  ||| S:1179 E:1191 ||| JJ
effects  ||| S:1191 E:1199 ||| NNS
on  ||| S:1199 E:1202 ||| IN
cells ||| S:1202 E:1207 ||| NNS
Some  ||| S:1210 E:1215 ||| DT
considerations  ||| S:1215 E:1230 ||| NNS
for  ||| S:1230 E:1234 ||| IN
microfluidic  ||| S:1234 E:1247 ||| JJ
devices  ||| S:1247 E:1255 ||| NNS
relating  ||| S:1255 E:1264 ||| VBG
to  ||| S:1264 E:1267 ||| TO
cell  ||| S:1267 E:1272 ||| NN
culture  ||| S:1272 E:1280 ||| NN
include ||| S:1280 E:1287 ||| VBP
:  ||| S:1287 E:1289 ||| :
Fabrication  ||| S:1289 E:1301 ||| NNP
material  ||| S:1301 E:1310 ||| NN
is  ||| S:1310 E:1313 ||| VBZ
crucial  ||| S:1313 E:1321 ||| JJ
as  ||| S:1321 E:1324 ||| IN
not  ||| S:1324 E:1328 ||| RB
all  ||| S:1328 E:1332 ||| DT
polymers  ||| S:1332 E:1341 ||| NNS
are  ||| S:1341 E:1345 ||| VBP
biocompatible ||| S:1345 E:1358 ||| VBN
,  ||| S:1358 E:1360 ||| ,
with  ||| S:1360 E:1365 ||| IN
some  ||| S:1365 E:1370 ||| DT
materials  ||| S:1370 E:1380 ||| NNS
such  ||| S:1380 E:1385 ||| JJ
as  ||| S:1385 E:1388 ||| IN
PDMS  ||| S:1388 E:1393 ||| NNP
causing  ||| S:1393 E:1401 ||| VBG
undesirable  ||| S:1401 E:1413 ||| JJ
adsorption  ||| S:1413 E:1424 ||| NN
or  ||| S:1424 E:1427 ||| CC
absorption  ||| S:1427 E:1438 ||| NN
of  ||| S:1438 E:1441 ||| IN
small  ||| S:1441 E:1447 ||| JJ
molecules ||| S:1447 E:1456 ||| NNS
.  ||| S:1456 E:1458 ||| .
Additionally ||| S:1458 E:1470 ||| RB
,  ||| S:1470 E:1472 ||| ,
uncured  ||| S:1472 E:1480 ||| FW
PDMS  ||| S:1480 E:1485 ||| FW
oligomers  ||| S:1485 E:1495 ||| FW
can  ||| S:1495 E:1499 ||| MD
leach  ||| S:1499 E:1505 ||| VB
into  ||| S:1505 E:1510 ||| IN
the  ||| S:1510 E:1514 ||| DT
cell  ||| S:1514 E:1519 ||| NN
culture  ||| S:1519 E:1527 ||| NN
media ||| S:1527 E:1532 ||| NNS
,  ||| S:1532 E:1534 ||| ,
which  ||| S:1534 E:1540 ||| WDT
can  ||| S:1540 E:1544 ||| MD
harm  ||| S:1544 E:1549 ||| VB
the  ||| S:1549 E:1553 ||| DT
microenvironment ||| S:1553 E:1569 ||| NN
.  ||| S:1569 E:1571 ||| .
As  ||| S:1571 E:1574 ||| IN
an  ||| S:1574 E:1577 ||| DT
alternative  ||| S:1577 E:1589 ||| NN
to  ||| S:1589 E:1592 ||| TO
commonly  ||| S:1592 E:1601 ||| VB
used  ||| S:1601 E:1606 ||| VBN
PDMS ||| S:1606 E:1610 ||| NNP
,  ||| S:1610 E:1612 ||| ,
there  ||| S:1612 E:1618 ||| EX
have  ||| S:1618 E:1623 ||| VBP
been  ||| S:1623 E:1628 ||| VBN
advances  ||| S:1628 E:1637 ||| NNS
in  ||| S:1637 E:1640 ||| IN
the  ||| S:1640 E:1644 ||| DT
use  ||| S:1644 E:1648 ||| NN
of  ||| S:1648 E:1651 ||| IN
thermoplastics  ||| S:1651 E:1666 ||| NNS
( ||| S:1666 E:1667 ||| -LRB-
e.g. ||| S:1667 E:1671 ||| NNP
,  ||| S:1671 E:1673 ||| ,
polystyrene ||| S:1673 E:1684 ||| NN
)  ||| S:1684 E:1686 ||| -RRB-
as  ||| S:1686 E:1689 ||| IN
a  ||| S:1689 E:1691 ||| DT
replacement  ||| S:1691 E:1703 ||| NN
material ||| S:1703 E:1711 ||| NN
Spatial  ||| S:1714 E:1722 ||| JJ
organization  ||| S:1722 E:1735 ||| NN
of  ||| S:1735 E:1738 ||| IN
cells  ||| S:1738 E:1744 ||| NNS
in  ||| S:1744 E:1747 ||| IN
microscale  ||| S:1747 E:1758 ||| JJ
devices  ||| S:1758 E:1766 ||| NNS
largely  ||| S:1766 E:1774 ||| RB
depends  ||| S:1774 E:1782 ||| VBZ
on  ||| S:1782 E:1785 ||| IN
the  ||| S:1785 E:1789 ||| DT
culture  ||| S:1789 E:1797 ||| NN
region  ||| S:1797 E:1804 ||| NN
geometry  ||| S:1804 E:1813 ||| NN
for  ||| S:1813 E:1817 ||| IN
cells  ||| S:1817 E:1823 ||| NNS
to  ||| S:1823 E:1826 ||| TO
perform  ||| S:1826 E:1834 ||| VB
functions  ||| S:1834 E:1844 ||| FW
"in  ||| S:1844 E:1848 ||| FW
vivo ||| S:1848 E:1852 ||| FW
" ||| S:1852 E:1853 ||| ''
.  ||| S:1853 E:1855 ||| .
For  ||| S:1855 E:1859 ||| IN
example ||| S:1859 E:1866 ||| NN
,  ||| S:1866 E:1868 ||| ,
long ||| S:1868 E:1872 ||| RB
,  ||| S:1872 E:1874 ||| ,
narrow  ||| S:1874 E:1881 ||| JJ
channels  ||| S:1881 E:1890 ||| NNS
may  ||| S:1890 E:1894 ||| MD
be  ||| S:1894 E:1897 ||| VB
desired  ||| S:1897 E:1905 ||| VBN
to  ||| S:1905 E:1908 ||| TO
culture  ||| S:1908 E:1916 ||| NN
neurons ||| S:1916 E:1923 ||| NN
.  ||| S:1923 E:1925 ||| .
The  ||| S:1925 E:1929 ||| DT
perfusion  ||| S:1929 E:1939 ||| JJ
system  ||| S:1939 E:1946 ||| NN
chosen  ||| S:1946 E:1953 ||| NNS
might  ||| S:1953 E:1959 ||| MD
also  ||| S:1959 E:1964 ||| RB
affect  ||| S:1964 E:1971 ||| VB
the  ||| S:1971 E:1975 ||| DT
geometry  ||| S:1975 E:1984 ||| NN
chosen ||| S:1984 E:1990 ||| VBN
.  ||| S:1990 E:1992 ||| .
For  ||| S:1992 E:1996 ||| IN
example ||| S:1996 E:2003 ||| NN
,  ||| S:2003 E:2005 ||| ,
in  ||| S:2005 E:2008 ||| IN
a  ||| S:2008 E:2010 ||| DT
system  ||| S:2010 E:2017 ||| NN
that  ||| S:2017 E:2022 ||| WDT
incorporates  ||| S:2022 E:2035 ||| VBZ
syringe  ||| S:2035 E:2043 ||| JJ
pumps ||| S:2043 E:2048 ||| NNS
,  ||| S:2048 E:2050 ||| ,
channels  ||| S:2050 E:2059 ||| NNS
for  ||| S:2059 E:2063 ||| IN
perfusion  ||| S:2063 E:2073 ||| JJ
inlet ||| S:2073 E:2078 ||| NN
,  ||| S:2078 E:2080 ||| ,
perfusion  ||| S:2080 E:2090 ||| JJ
outlet ||| S:2090 E:2096 ||| NN
,  ||| S:2096 E:2098 ||| ,
waste ||| S:2098 E:2103 ||| NN
,  ||| S:2103 E:2105 ||| ,
and  ||| S:2105 E:2109 ||| CC
cell  ||| S:2109 E:2114 ||| NN
loading  ||| S:2114 E:2122 ||| NN
would  ||| S:2122 E:2128 ||| MD
need  ||| S:2128 E:2133 ||| VB
to  ||| S:2133 E:2136 ||| TO
be  ||| S:2136 E:2139 ||| VB
added  ||| S:2139 E:2145 ||| VBN
for  ||| S:2145 E:2149 ||| IN
the  ||| S:2149 E:2153 ||| DT
cell  ||| S:2153 E:2158 ||| NN
culture  ||| S:2158 E:2166 ||| NN
maintenance ||| S:2166 E:2177 ||| NN
.  ||| S:2177 E:2179 ||| .
Perfusion  ||| S:2179 E:2189 ||| NNP
in  ||| S:2189 E:2192 ||| IN
microfluidic  ||| S:2192 E:2205 ||| JJ
cell  ||| S:2205 E:2210 ||| NN
culture  ||| S:2210 E:2218 ||| NN
is  ||| S:2218 E:2221 ||| VBZ
important  ||| S:2221 E:2231 ||| JJ
to  ||| S:2231 E:2234 ||| TO
enable  ||| S:2234 E:2241 ||| VB
long  ||| S:2241 E:2246 ||| JJ
culture  ||| S:2246 E:2254 ||| NN
periods  ||| S:2254 E:2262 ||| NNS
on-chip  ||| S:2262 E:2270 ||| JJ
and  ||| S:2270 E:2274 ||| CC
cell  ||| S:2274 E:2279 ||| FW
differentiation ||| S:2279 E:2294 ||| FW
Other  ||| S:2297 E:2303 ||| JJ
critical  ||| S:2303 E:2312 ||| JJ
aspects  ||| S:2312 E:2320 ||| NNS
for  ||| S:2320 E:2324 ||| IN
controlling  ||| S:2324 E:2336 ||| VBG
the  ||| S:2336 E:2340 ||| DT
microenvironment  ||| S:2340 E:2357 ||| NNS
include ||| S:2357 E:2364 ||| VBP
:  ||| S:2364 E:2366 ||| :
cell  ||| S:2366 E:2371 ||| NN
seeding  ||| S:2371 E:2379 ||| NN
density ||| S:2379 E:2386 ||| NN
,  ||| S:2386 E:2388 ||| ,
reduction  ||| S:2388 E:2398 ||| NN
of  ||| S:2398 E:2401 ||| IN
air  ||| S:2401 E:2405 ||| NN
bubbles  ||| S:2405 E:2413 ||| NNS
as  ||| S:2413 E:2416 ||| IN
they  ||| S:2416 E:2421 ||| PRP
can  ||| S:2421 E:2425 ||| MD
rupture  ||| S:2425 E:2433 ||| VB
cell  ||| S:2433 E:2438 ||| NN
membranes ||| S:2438 E:2447 ||| NN
,  ||| S:2447 E:2449 ||| ,
evaporation  ||| S:2449 E:2461 ||| NN
of  ||| S:2461 E:2464 ||| IN
media  ||| S:2464 E:2470 ||| NNS
due  ||| S:2470 E:2474 ||| JJ
to  ||| S:2474 E:2477 ||| TO
an  ||| S:2477 E:2480 ||| DT
insufficiently  ||| S:2480 E:2495 ||| JJ
humid  ||| S:2495 E:2501 ||| JJ
environment ||| S:2501 E:2512 ||| NN
,  ||| S:2512 E:2514 ||| ,
and  ||| S:2514 E:2518 ||| CC
cell  ||| S:2518 E:2523 ||| NN
culture  ||| S:2523 E:2531 ||| NN
maintenance  ||| S:2531 E:2543 ||| NN
( ||| S:2543 E:2544 ||| -LRB-
i.e.  ||| S:2544 E:2549 ||| FW
regular ||| S:2549 E:2556 ||| FW
,  ||| S:2556 E:2558 ||| ,
timely  ||| S:2558 E:2565 ||| JJ
media  ||| S:2565 E:2571 ||| NNS
changes ||| S:2571 E:2578 ||| NNS
) ||| S:2578 E:2579 ||| -RRB-
Cell ||| S:2582 E:2586 ||| NN
's  ||| S:2586 E:2589 ||| POS
health  ||| S:2589 E:2596 ||| NN
is  ||| S:2596 E:2599 ||| VBZ
defined  ||| S:2599 E:2607 ||| VBN
as  ||| S:2607 E:2610 ||| IN
the  ||| S:2610 E:2614 ||| DT
collective  ||| S:2614 E:2625 ||| JJ
equilibrium  ||| S:2625 E:2637 ||| NN
activities  ||| S:2637 E:2648 ||| NNS
of  ||| S:2648 E:2651 ||| IN
essential  ||| S:2651 E:2661 ||| JJ
and  ||| S:2661 E:2665 ||| CC
specialized  ||| S:2665 E:2677 ||| JJ
cellular  ||| S:2677 E:2686 ||| JJ
processes ||| S:2686 E:2695 ||| NNS
;  ||| S:2695 E:2697 ||| :
while  ||| S:2697 E:2703 ||| IN
a  ||| S:2703 E:2705 ||| DT
cell  ||| S:2705 E:2710 ||| NN
stressor  ||| S:2710 E:2719 ||| NN
is  ||| S:2719 E:2722 ||| VBZ
defined  ||| S:2722 E:2730 ||| VBN
as  ||| S:2730 E:2733 ||| IN
a  ||| S:2733 E:2735 ||| DT
stimulus  ||| S:2735 E:2744 ||| NN
that  ||| S:2744 E:2749 ||| WDT
causes  ||| S:2749 E:2756 ||| VBZ
excursion  ||| S:2756 E:2766 ||| VBN
from  ||| S:2766 E:2771 ||| IN
its  ||| S:2771 E:2775 ||| PRP$
equilibrium  ||| S:2775 E:2787 ||| JJ
state ||| S:2787 E:2792 ||| NN
.  ||| S:2792 E:2794 ||| .
Hence ||| S:2794 E:2799 ||| RB
,  ||| S:2799 E:2801 ||| ,
cell  ||| S:2801 E:2806 ||| NN
health  ||| S:2806 E:2813 ||| NN
may  ||| S:2813 E:2817 ||| MD
be  ||| S:2817 E:2820 ||| VB
perturbed  ||| S:2820 E:2830 ||| VBN
within  ||| S:2830 E:2837 ||| IN
microsystems  ||| S:2837 E:2850 ||| VBG
based  ||| S:2850 E:2856 ||| VBN
on  ||| S:2856 E:2859 ||| IN
platform  ||| S:2859 E:2868 ||| NN
design  ||| S:2868 E:2875 ||| NN
or  ||| S:2875 E:2878 ||| CC
operating  ||| S:2878 E:2888 ||| VBG
conditions ||| S:2888 E:2898 ||| NNS
.  ||| S:2898 E:2900 ||| .
Exposure  ||| S:2900 E:2909 ||| NN
to  ||| S:2909 E:2912 ||| TO
stressors  ||| S:2912 E:2922 ||| VB
within  ||| S:2922 E:2929 ||| IN
microsystems  ||| S:2929 E:2942 ||| NNS
can  ||| S:2942 E:2946 ||| MD
impact  ||| S:2946 E:2953 ||| VB
cells  ||| S:2953 E:2959 ||| NNS
through  ||| S:2959 E:2967 ||| IN
direct  ||| S:2967 E:2974 ||| JJ
and  ||| S:2974 E:2978 ||| CC
indirect  ||| S:2978 E:2987 ||| JJ
ways ||| S:2987 E:2991 ||| NNS
.  ||| S:2991 E:2993 ||| .
Therefore ||| S:2993 E:3002 ||| RB
,  ||| S:3002 E:3004 ||| ,
it  ||| S:3004 E:3007 ||| PRP
is  ||| S:3007 E:3010 ||| VBZ
important  ||| S:3010 E:3020 ||| JJ
to  ||| S:3020 E:3023 ||| TO
design  ||| S:3023 E:3030 ||| VB
the  ||| S:3030 E:3034 ||| DT
microfluidics  ||| S:3034 E:3048 ||| JJ
system  ||| S:3048 E:3055 ||| NN
for  ||| S:3055 E:3059 ||| IN
cell  ||| S:3059 E:3064 ||| NN
culture  ||| S:3064 E:3072 ||| NN
in  ||| S:3072 E:3075 ||| IN
a  ||| S:3075 E:3077 ||| DT
manner  ||| S:3077 E:3084 ||| NN
that  ||| S:3084 E:3089 ||| IN
minimizes  ||| S:3089 E:3099 ||| JJ
cell  ||| S:3099 E:3104 ||| NN
stress  ||| S:3104 E:3111 ||| NN
situations ||| S:3111 E:3121 ||| NNS
.  ||| S:3121 E:3123 ||| .
For  ||| S:3123 E:3127 ||| IN
example ||| S:3127 E:3134 ||| NN
,  ||| S:3134 E:3136 ||| ,
by  ||| S:3136 E:3139 ||| IN
minimizing  ||| S:3139 E:3150 ||| VBG
cell  ||| S:3150 E:3155 ||| NN
suspension ||| S:3155 E:3165 ||| NN
,  ||| S:3165 E:3167 ||| ,
by  ||| S:3167 E:3170 ||| IN
avoiding  ||| S:3170 E:3179 ||| VBG
abrupt  ||| S:3179 E:3186 ||| JJ
geometries  ||| S:3186 E:3197 ||| NNS
( ||| S:3197 E:3198 ||| -LRB-
which  ||| S:3198 E:3204 ||| WDT
tend  ||| S:3204 E:3209 ||| VBP
to  ||| S:3209 E:3212 ||| TO
favor  ||| S:3212 E:3218 ||| VB
bubble  ||| S:3218 E:3225 ||| JJ
formation ||| S:3225 E:3234 ||| NN
) ||| S:3234 E:3235 ||| -RRB-
,  ||| S:3235 E:3237 ||| ,
designing  ||| S:3237 E:3247 ||| VBG
higher  ||| S:3247 E:3254 ||| JJR
and  ||| S:3254 E:3258 ||| CC
wider  ||| S:3258 E:3264 ||| JJR
channels  ||| S:3264 E:3273 ||| NNS
( ||| S:3273 E:3274 ||| -LRB-
to  ||| S:3274 E:3277 ||| TO
avoid  ||| S:3277 E:3283 ||| VB
shear  ||| S:3283 E:3289 ||| JJ
stress ||| S:3289 E:3295 ||| NN
) ||| S:3295 E:3296 ||| -RRB-
,  ||| S:3296 E:3298 ||| ,
avoid  ||| S:3298 E:3304 ||| VB
thermosensitive  ||| S:3304 E:3320 ||| JJ
hydrogels. ||| S:3320 E:3330 ||| NN
. ||| S:3330 E:3331 ||| .
Some  ||| S:3334 E:3339 ||| DT
of  ||| S:3339 E:3342 ||| IN
the  ||| S:3342 E:3346 ||| DT
major  ||| S:3346 E:3352 ||| JJ
advantages  ||| S:3352 E:3363 ||| NNS
of  ||| S:3363 E:3366 ||| IN
microfluidic  ||| S:3366 E:3379 ||| JJ
cell  ||| S:3379 E:3384 ||| NN
culture  ||| S:3384 E:3392 ||| NN
include  ||| S:3392 E:3400 ||| VBP
reduced  ||| S:3400 E:3408 ||| VBN
sample  ||| S:3408 E:3415 ||| NN
volumes  ||| S:3415 E:3423 ||| NNS
( ||| S:3423 E:3424 ||| -LRB-
especially  ||| S:3424 E:3435 ||| RB
important  ||| S:3435 E:3445 ||| JJ
when  ||| S:3445 E:3450 ||| WRB
using  ||| S:3450 E:3456 ||| VBG
primary  ||| S:3456 E:3464 ||| JJ
cells ||| S:3464 E:3469 ||| NNS
,  ||| S:3469 E:3471 ||| ,
which  ||| S:3471 E:3477 ||| WDT
are  ||| S:3477 E:3481 ||| VBP
often  ||| S:3481 E:3487 ||| RB
limited ||| S:3487 E:3494 ||| VBN
)  ||| S:3494 E:3496 ||| -RRB-
and  ||| S:3496 E:3500 ||| CC
the  ||| S:3500 E:3504 ||| DT
flexibility  ||| S:3504 E:3516 ||| NN
to  ||| S:3516 E:3519 ||| TO
customize  ||| S:3519 E:3529 ||| VB
and  ||| S:3529 E:3533 ||| CC
study  ||| S:3533 E:3539 ||| VB
multiple  ||| S:3539 E:3548 ||| JJ
microenvironments  ||| S:3548 E:3566 ||| NN
within  ||| S:3566 E:3573 ||| IN
the  ||| S:3573 E:3577 ||| DT
same  ||| S:3577 E:3582 ||| JJ
device ||| S:3582 E:3588 ||| NN
.  ||| S:3588 E:3590 ||| .
A  ||| S:3590 E:3592 ||| DT
reduced  ||| S:3592 E:3600 ||| JJ
cell  ||| S:3600 E:3605 ||| NN
population  ||| S:3605 E:3616 ||| NN
can  ||| S:3616 E:3620 ||| MD
also  ||| S:3620 E:3625 ||| RB
be  ||| S:3625 E:3628 ||| VB
used  ||| S:3628 E:3633 ||| VBN
in  ||| S:3633 E:3636 ||| IN
a  ||| S:3636 E:3638 ||| DT
microscale  ||| S:3638 E:3649 ||| JJ
system  ||| S:3649 E:3656 ||| NN
( ||| S:3656 E:3657 ||| -LRB-
e.g. ||| S:3657 E:3661 ||| NNP
,  ||| S:3661 E:3663 ||| ,
a  ||| S:3663 E:3665 ||| DT
few  ||| S:3665 E:3669 ||| JJ
hundred  ||| S:3669 E:3677 ||| CD
cells ||| S:3677 E:3682 ||| NNS
)  ||| S:3682 E:3684 ||| -RRB-
in  ||| S:3684 E:3687 ||| IN
comparison  ||| S:3687 E:3698 ||| NN
to  ||| S:3698 E:3701 ||| TO
macroscale  ||| S:3701 E:3712 ||| VB
culture  ||| S:3712 E:3720 ||| NN
systems  ||| S:3720 E:3728 ||| NNS
( ||| S:3728 E:3729 ||| -LRB-
which  ||| S:3729 E:3735 ||| WDT
often  ||| S:3735 E:3741 ||| RB
require  ||| S:3741 E:3749 ||| VB
10  ||| S:3749 E:3752 ||| CD
–  ||| S:3752 E:3754 ||| CD
10  ||| S:3754 E:3757 ||| CD
cells ||| S:3757 E:3762 ||| NNS
) ||| S:3762 E:3763 ||| -RRB-
;  ||| S:3763 E:3765 ||| :
this  ||| S:3765 E:3770 ||| DT
can  ||| S:3770 E:3774 ||| MD
make  ||| S:3774 E:3779 ||| VB
studying  ||| S:3779 E:3788 ||| VBG
certain  ||| S:3788 E:3796 ||| JJ
cell-cell  ||| S:3796 E:3806 ||| JJ
interactions  ||| S:3806 E:3819 ||| NNS
more  ||| S:3819 E:3824 ||| RBR
accessible ||| S:3824 E:3834 ||| JJ
.  ||| S:3834 E:3836 ||| .
These  ||| S:3836 E:3842 ||| DT
reduced  ||| S:3842 E:3850 ||| JJ
cell  ||| S:3850 E:3855 ||| NN
numbers  ||| S:3855 E:3863 ||| NNS
make  ||| S:3863 E:3868 ||| VBP
studying  ||| S:3868 E:3877 ||| VBG
non-dividing  ||| S:3877 E:3890 ||| JJ
or  ||| S:3890 E:3893 ||| CC
slow  ||| S:3893 E:3898 ||| JJ
dividing  ||| S:3898 E:3907 ||| JJ
cells  ||| S:3907 E:3913 ||| NNS
( ||| S:3913 E:3914 ||| -LRB-
e.g. ||| S:3914 E:3918 ||| NNP
,  ||| S:3918 E:3920 ||| ,
stem  ||| S:3920 E:3925 ||| VBP
cells ||| S:3925 E:3930 ||| NNS
)  ||| S:3930 E:3932 ||| -RRB-
easier  ||| S:3932 E:3939 ||| JJR
than  ||| S:3939 E:3944 ||| IN
traditional  ||| S:3944 E:3956 ||| JJ
culture  ||| S:3956 E:3964 ||| NN
methods  ||| S:3964 E:3972 ||| NNS
( ||| S:3972 E:3973 ||| -LRB-
e.g. ||| S:3973 E:3977 ||| NNP
,  ||| S:3977 E:3979 ||| ,
flasks ||| S:3979 E:3985 ||| NN
,  ||| S:3985 E:3987 ||| ,
petri  ||| S:3987 E:3993 ||| JJ
dishes ||| S:3993 E:3999 ||| NNS
,  ||| S:3999 E:4001 ||| ,
or  ||| S:4001 E:4004 ||| CC
well  ||| S:4004 E:4009 ||| RB
plates ||| S:4009 E:4015 ||| CD
)  ||| S:4015 E:4017 ||| -RRB-
due  ||| S:4017 E:4021 ||| JJ
to  ||| S:4021 E:4024 ||| TO
the  ||| S:4024 E:4028 ||| DT
smaller  ||| S:4028 E:4036 ||| JJR
sample  ||| S:4036 E:4043 ||| NN
volumes ||| S:4043 E:4050 ||| NNS
.  ||| S:4050 E:4052 ||| .
Given  ||| S:4052 E:4058 ||| VBN
the  ||| S:4058 E:4062 ||| DT
small  ||| S:4062 E:4068 ||| JJ
dimensions  ||| S:4068 E:4079 ||| NNS
in  ||| S:4079 E:4082 ||| IN
microfluidics ||| S:4082 E:4095 ||| NN
,  ||| S:4095 E:4097 ||| ,
laminar  ||| S:4097 E:4105 ||| JJ
flow  ||| S:4105 E:4110 ||| NN
can  ||| S:4110 E:4114 ||| MD
be  ||| S:4114 E:4117 ||| VB
achieved ||| S:4117 E:4125 ||| VBN
,  ||| S:4125 E:4127 ||| ,
allowing  ||| S:4127 E:4136 ||| VBG
manipulations  ||| S:4136 E:4150 ||| NNS
with  ||| S:4150 E:4155 ||| IN
the  ||| S:4155 E:4159 ||| DT
culture  ||| S:4159 E:4167 ||| NN
system  ||| S:4167 E:4174 ||| NN
to  ||| S:4174 E:4177 ||| TO
be  ||| S:4177 E:4180 ||| VB
done  ||| S:4180 E:4185 ||| VBN
easily  ||| S:4185 E:4192 ||| RB
without  ||| S:4192 E:4200 ||| IN
affecting  ||| S:4200 E:4210 ||| VBG
other  ||| S:4210 E:4216 ||| JJ
culture  ||| S:4216 E:4224 ||| NN
chambers ||| S:4224 E:4232 ||| NNS
.  ||| S:4232 E:4234 ||| .
Laminar  ||| S:4234 E:4242 ||| JJ
flow  ||| S:4242 E:4247 ||| NN
is  ||| S:4247 E:4250 ||| VBZ
also  ||| S:4250 E:4255 ||| RB
useful  ||| S:4255 E:4262 ||| JJ
as  ||| S:4262 E:4265 ||| RB
is  ||| S:4265 E:4268 ||| VBZ
it  ||| S:4268 E:4271 ||| PRP
mimics  ||| S:4271 E:4278 ||| VBZ
"in  ||| S:4278 E:4282 ||| CD
vivo ||| S:4282 E:4286 ||| NN
"  ||| S:4286 E:4288 ||| ``
fluid  ||| S:4288 E:4294 ||| JJ
dynamics  ||| S:4294 E:4303 ||| NNS
more  ||| S:4303 E:4308 ||| RBR
accurately ||| S:4308 E:4318 ||| RB
,  ||| S:4318 E:4320 ||| ,
often  ||| S:4320 E:4326 ||| RB
making  ||| S:4326 E:4333 ||| VBG
microscale  ||| S:4333 E:4344 ||| JJ
culture  ||| S:4344 E:4352 ||| NN
more  ||| S:4352 E:4357 ||| RBR
relevant  ||| S:4357 E:4366 ||| JJ
than  ||| S:4366 E:4371 ||| IN
traditional  ||| S:4371 E:4383 ||| JJ
culture  ||| S:4383 E:4391 ||| NN
methods ||| S:4391 E:4398 ||| NNS
.  ||| S:4398 E:4400 ||| .
Compartmentalized  ||| S:4400 E:4418 ||| JJ
microfluidic  ||| S:4418 E:4431 ||| JJ
cultures  ||| S:4431 E:4440 ||| NNS
have  ||| S:4440 E:4445 ||| VBP
also  ||| S:4445 E:4450 ||| RB
been  ||| S:4450 E:4455 ||| VBN
combined  ||| S:4455 E:4464 ||| VBN
with  ||| S:4464 E:4469 ||| IN
live  ||| S:4469 E:4474 ||| JJ
cell  ||| S:4474 E:4479 ||| NN
calcium  ||| S:4479 E:4487 ||| NN
imaging ||| S:4487 E:4494 ||| NN
,  ||| S:4494 E:4496 ||| ,
where  ||| S:4496 E:4502 ||| WRB
depolarizing  ||| S:4502 E:4515 ||| JJ
stimuli  ||| S:4515 E:4523 ||| NNS
have  ||| S:4523 E:4528 ||| VBP
been  ||| S:4528 E:4533 ||| VBN
delivered  ||| S:4533 E:4543 ||| VBN
to  ||| S:4543 E:4546 ||| TO
the  ||| S:4546 E:4550 ||| DT
peripheral  ||| S:4550 E:4561 ||| JJ
terminals  ||| S:4561 E:4571 ||| NNS
of  ||| S:4571 E:4574 ||| IN
neurons ||| S:4574 E:4581 ||| NN
,  ||| S:4581 E:4583 ||| ,
and  ||| S:4583 E:4587 ||| CC
calcium  ||| S:4587 E:4595 ||| JJ
responses  ||| S:4595 E:4605 ||| NNS
recorded  ||| S:4605 E:4614 ||| VBN
in  ||| S:4614 E:4617 ||| IN
the  ||| S:4617 E:4621 ||| DT
cell  ||| S:4621 E:4626 ||| NN
body ||| S:4626 E:4630 ||| NN
.  ||| S:4630 E:4632 ||| .
This  ||| S:4632 E:4637 ||| DT
technique  ||| S:4637 E:4647 ||| NN
has  ||| S:4647 E:4651 ||| VBZ
demonstrated  ||| S:4651 E:4664 ||| VBN
a  ||| S:4664 E:4666 ||| DT
stark  ||| S:4666 E:4672 ||| JJ
difference  ||| S:4672 E:4683 ||| NN
in  ||| S:4683 E:4686 ||| IN
the  ||| S:4686 E:4690 ||| DT
sensitivity  ||| S:4690 E:4702 ||| NN
of  ||| S:4702 E:4705 ||| IN
the  ||| S:4705 E:4709 ||| DT
peripheral  ||| S:4709 E:4720 ||| JJ
terminals  ||| S:4720 E:4730 ||| NNS
compared  ||| S:4730 E:4739 ||| VBN
to  ||| S:4739 E:4742 ||| TO
the  ||| S:4742 E:4746 ||| DT
neuronal  ||| S:4746 E:4755 ||| JJ
cell  ||| S:4755 E:4760 ||| NN
body  ||| S:4760 E:4765 ||| NN
to  ||| S:4765 E:4768 ||| TO
certain  ||| S:4768 E:4776 ||| JJ
stimuli  ||| S:4776 E:4784 ||| NNS
such  ||| S:4784 E:4789 ||| JJ
as  ||| S:4789 E:4792 ||| IN
protons ||| S:4792 E:4799 ||| NN
.  ||| S:4799 E:4801 ||| .
This  ||| S:4801 E:4806 ||| DT
gives  ||| S:4806 E:4812 ||| VBZ
an  ||| S:4812 E:4815 ||| DT
excellent  ||| S:4815 E:4825 ||| JJ
example  ||| S:4825 E:4833 ||| NN
as  ||| S:4833 E:4836 ||| IN
to  ||| S:4836 E:4839 ||| TO
why  ||| S:4839 E:4843 ||| WRB
it  ||| S:4843 E:4846 ||| PRP
is  ||| S:4846 E:4849 ||| VBZ
so  ||| S:4849 E:4852 ||| RB
important  ||| S:4852 E:4862 ||| JJ
to  ||| S:4862 E:4865 ||| TO
study  ||| S:4865 E:4871 ||| VB
the  ||| S:4871 E:4875 ||| DT
peripheral  ||| S:4875 E:4886 ||| JJ
terminals  ||| S:4886 E:4896 ||| NNS
in  ||| S:4896 E:4899 ||| IN
isolation  ||| S:4899 E:4909 ||| NN
using  ||| S:4909 E:4915 ||| VBG
microfluidic  ||| S:4915 E:4928 ||| JJ
cell  ||| S:4928 E:4933 ||| NN
culture  ||| S:4933 E:4941 ||| NN
devices ||| S:4941 E:4948 ||| NNS
Traditional  ||| S:4951 E:4963 ||| JJ
two-dimensional  ||| S:4963 E:4979 ||| JJ
( ||| S:4979 E:4980 ||| -LRB-
2D ||| S:4980 E:4982 ||| NNP
)  ||| S:4982 E:4984 ||| -RRB-
cell  ||| S:4984 E:4989 ||| NN
culture  ||| S:4989 E:4997 ||| NN
is  ||| S:4997 E:5000 ||| VBZ
cell  ||| S:5000 E:5005 ||| NN
culture  ||| S:5005 E:5013 ||| NN
that  ||| S:5013 E:5018 ||| WDT
takes  ||| S:5018 E:5024 ||| VBZ
place  ||| S:5024 E:5030 ||| NN
on  ||| S:5030 E:5033 ||| IN
a  ||| S:5033 E:5035 ||| DT
flat  ||| S:5035 E:5040 ||| JJ
surface ||| S:5040 E:5047 ||| NN
,  ||| S:5047 E:5049 ||| ,
e.g.  ||| S:5049 E:5054 ||| CD
the  ||| S:5054 E:5058 ||| DT
bottom  ||| S:5058 E:5065 ||| NN
of  ||| S:5065 E:5068 ||| IN
a  ||| S:5068 E:5070 ||| DT
well-plate ||| S:5070 E:5080 ||| JJ
,  ||| S:5080 E:5082 ||| ,
and  ||| S:5082 E:5086 ||| CC
is  ||| S:5086 E:5089 ||| VBZ
known  ||| S:5089 E:5095 ||| VBN
as  ||| S:5095 E:5098 ||| IN
the  ||| S:5098 E:5102 ||| DT
conventional  ||| S:5102 E:5115 ||| JJ
method ||| S:5115 E:5121 ||| NN
.  ||| S:5121 E:5123 ||| .
While  ||| S:5123 E:5129 ||| IN
these  ||| S:5129 E:5135 ||| DT
platforms  ||| S:5135 E:5145 ||| NNS
are  ||| S:5145 E:5149 ||| VBP
useful  ||| S:5149 E:5156 ||| JJ
for  ||| S:5156 E:5160 ||| IN
growing  ||| S:5160 E:5168 ||| VBG
and  ||| S:5168 E:5172 ||| CC
passaging  ||| S:5172 E:5182 ||| JJ
cells  ||| S:5182 E:5188 ||| NNS
to  ||| S:5188 E:5191 ||| TO
be  ||| S:5191 E:5194 ||| VB
used  ||| S:5194 E:5199 ||| VBN
in  ||| S:5199 E:5202 ||| IN
subsequent  ||| S:5202 E:5213 ||| JJ
experiments ||| S:5213 E:5224 ||| NNS
,  ||| S:5224 E:5226 ||| ,
they  ||| S:5226 E:5231 ||| PRP
are  ||| S:5231 E:5235 ||| VBP
not  ||| S:5235 E:5239 ||| RB
ideal  ||| S:5239 E:5245 ||| JJ
environments  ||| S:5245 E:5258 ||| NNS
to  ||| S:5258 E:5261 ||| TO
monitor  ||| S:5261 E:5269 ||| VB
cell  ||| S:5269 E:5274 ||| NN
responses  ||| S:5274 E:5284 ||| NNS
to  ||| S:5284 E:5287 ||| TO
stimuli  ||| S:5287 E:5295 ||| VB
as  ||| S:5295 E:5298 ||| IN
cells  ||| S:5298 E:5304 ||| NNS
cannot  ||| S:5304 E:5311 ||| VBP
freely  ||| S:5311 E:5318 ||| RB
move  ||| S:5318 E:5323 ||| VB
or  ||| S:5323 E:5326 ||| CC
perform  ||| S:5326 E:5334 ||| VB
functions  ||| S:5334 E:5344 ||| NNS
as  ||| S:5344 E:5347 ||| IN
observed  ||| S:5347 E:5356 ||| FW
"in  ||| S:5356 E:5360 ||| FW
vivo ||| S:5360 E:5364 ||| FW
"  ||| S:5364 E:5366 ||| ''
that  ||| S:5366 E:5371 ||| WDT
are  ||| S:5371 E:5375 ||| VBP
dependent  ||| S:5375 E:5385 ||| JJ
on  ||| S:5385 E:5388 ||| IN
cell-extracellular  ||| S:5388 E:5407 ||| JJ
matrix  ||| S:5407 E:5414 ||| JJ
material  ||| S:5414 E:5423 ||| NN
interactions ||| S:5423 E:5435 ||| NNS
.  ||| S:5435 E:5437 ||| .
To  ||| S:5437 E:5440 ||| TO
address  ||| S:5440 E:5448 ||| VB
this  ||| S:5448 E:5453 ||| DT
issue  ||| S:5453 E:5459 ||| NN
many  ||| S:5459 E:5464 ||| JJ
methods  ||| S:5464 E:5472 ||| NNS
have  ||| S:5472 E:5477 ||| VBP
been  ||| S:5477 E:5482 ||| VBN
developed  ||| S:5482 E:5492 ||| VBN
to  ||| S:5492 E:5495 ||| TO
create  ||| S:5495 E:5502 ||| VB
a  ||| S:5502 E:5504 ||| DT
three-dimensional  ||| S:5504 E:5522 ||| JJ
( ||| S:5522 E:5523 ||| -LRB-
3D ||| S:5523 E:5525 ||| NNP
)  ||| S:5525 E:5527 ||| -RRB-
native  ||| S:5527 E:5534 ||| JJ
cell  ||| S:5534 E:5539 ||| NN
environment ||| S:5539 E:5550 ||| NN
.  ||| S:5550 E:5552 ||| .
One  ||| S:5552 E:5556 ||| CD
example  ||| S:5556 E:5564 ||| NN
of  ||| S:5564 E:5567 ||| IN
a  ||| S:5567 E:5569 ||| DT
3D  ||| S:5569 E:5572 ||| JJ
method  ||| S:5572 E:5579 ||| NN
is  ||| S:5579 E:5582 ||| VBZ
the  ||| S:5582 E:5586 ||| DT
handing  ||| S:5586 E:5594 ||| JJ
drop ||| S:5594 E:5598 ||| NN
,  ||| S:5598 E:5600 ||| ,
where  ||| S:5600 E:5606 ||| WRB
a  ||| S:5606 E:5608 ||| DT
droplet  ||| S:5608 E:5616 ||| NN
with  ||| S:5616 E:5621 ||| IN
growing  ||| S:5621 E:5629 ||| VBG
cells  ||| S:5629 E:5635 ||| NNS
is  ||| S:5635 E:5638 ||| VBZ
suspended  ||| S:5638 E:5648 ||| VBN
and  ||| S:5648 E:5652 ||| CC
hangs  ||| S:5652 E:5658 ||| JJ
downwards ||| S:5658 E:5667 ||| NN
,  ||| S:5667 E:5669 ||| ,
which  ||| S:5669 E:5675 ||| WDT
allows  ||| S:5675 E:5682 ||| VBZ
cells  ||| S:5682 E:5688 ||| NNS
to  ||| S:5688 E:5691 ||| TO
grow  ||| S:5691 E:5696 ||| VB
around  ||| S:5696 E:5703 ||| RP
and  ||| S:5703 E:5707 ||| CC
atop  ||| S:5707 E:5712 ||| NN
of  ||| S:5712 E:5715 ||| IN
one  ||| S:5715 E:5719 ||| CD
another ||| S:5719 E:5726 ||| DT
,  ||| S:5726 E:5728 ||| ,
forming  ||| S:5728 E:5736 ||| VBG
a  ||| S:5736 E:5738 ||| DT
spheroid ||| S:5738 E:5746 ||| NN
.  ||| S:5746 E:5748 ||| .
The  ||| S:5748 E:5752 ||| DT
hanging  ||| S:5752 E:5760 ||| JJ
drop  ||| S:5760 E:5765 ||| NN
method  ||| S:5765 E:5772 ||| NN
has  ||| S:5772 E:5776 ||| VBZ
been  ||| S:5776 E:5781 ||| VBN
used  ||| S:5781 E:5786 ||| VBN
to  ||| S:5786 E:5789 ||| TO
culture  ||| S:5789 E:5797 ||| NN
tumor  ||| S:5797 E:5803 ||| NN
cells  ||| S:5803 E:5809 ||| NNS
but  ||| S:5809 E:5813 ||| CC
is  ||| S:5813 E:5816 ||| VBZ
limited  ||| S:5816 E:5824 ||| VBN
to  ||| S:5824 E:5827 ||| TO
the  ||| S:5827 E:5831 ||| DT
geometry  ||| S:5831 E:5840 ||| NN
of  ||| S:5840 E:5843 ||| IN
a  ||| S:5843 E:5845 ||| DT
sphere ||| S:5845 E:5851 ||| NN
.  ||| S:5851 E:5853 ||| .
Since  ||| S:5853 E:5859 ||| IN
the  ||| S:5859 E:5863 ||| DT
advent  ||| S:5863 E:5870 ||| NN
of  ||| S:5870 E:5873 ||| IN
poly ||| S:5873 E:5877 ||| NNS
( ||| S:5877 E:5878 ||| -LRB-
dimethylsiloxane ||| S:5878 E:5894 ||| LS
)  ||| S:5894 E:5896 ||| -RRB-
( ||| S:5896 E:5897 ||| -LRB-
PDMS ||| S:5897 E:5901 ||| NNP
)  ||| S:5901 E:5903 ||| -RRB-
microfluidic  ||| S:5903 E:5916 ||| JJ
device  ||| S:5916 E:5923 ||| NN
fabrication  ||| S:5923 E:5935 ||| NN
through  ||| S:5935 E:5943 ||| IN
soft  ||| S:5943 E:5948 ||| JJ
lithography  ||| S:5948 E:5960 ||| JJ
microfluidic  ||| S:5960 E:5973 ||| JJ
devices  ||| S:5973 E:5981 ||| NNS
have  ||| S:5981 E:5986 ||| VBP
progressed  ||| S:5986 E:5997 ||| VBN
and  ||| S:5997 E:6001 ||| CC
have  ||| S:6001 E:6006 ||| VBP
proven  ||| S:6006 E:6013 ||| VBN
to  ||| S:6013 E:6016 ||| TO
be  ||| S:6016 E:6019 ||| VB
very  ||| S:6019 E:6024 ||| RB
beneficial  ||| S:6024 E:6035 ||| JJ
for  ||| S:6035 E:6039 ||| IN
mimicking  ||| S:6039 E:6049 ||| VBG
a  ||| S:6049 E:6051 ||| DT
natural  ||| S:6051 E:6059 ||| JJ
3D  ||| S:6059 E:6062 ||| CD
environment  ||| S:6062 E:6074 ||| NN
for  ||| S:6074 E:6078 ||| IN
cell  ||| S:6078 E:6083 ||| NN
culture ||| S:6083 E:6090 ||| NN
Microfluidic  ||| S:6093 E:6106 ||| JJ
devices  ||| S:6106 E:6114 ||| NNS
make  ||| S:6114 E:6119 ||| VBP
possible  ||| S:6119 E:6128 ||| JJ
the  ||| S:6128 E:6132 ||| DT
study  ||| S:6132 E:6138 ||| NN
of  ||| S:6138 E:6141 ||| IN
a  ||| S:6141 E:6143 ||| DT
single  ||| S:6143 E:6150 ||| JJ
cell  ||| S:6150 E:6155 ||| NN
to  ||| S:6155 E:6158 ||| TO
a  ||| S:6158 E:6160 ||| DT
few  ||| S:6160 E:6164 ||| JJ
hundred  ||| S:6164 E:6172 ||| CD
cells  ||| S:6172 E:6178 ||| NNS
in  ||| S:6178 E:6181 ||| IN
a  ||| S:6181 E:6183 ||| DT
3D  ||| S:6183 E:6186 ||| JJ
environment ||| S:6186 E:6197 ||| NN
.  ||| S:6197 E:6199 ||| .
Comparatively ||| S:6199 E:6212 ||| RB
,  ||| S:6212 E:6214 ||| ,
macroscopic  ||| S:6214 E:6226 ||| CD
2D  ||| S:6226 E:6229 ||| CD
cultures  ||| S:6229 E:6238 ||| NNS
have  ||| S:6238 E:6243 ||| VBP
10  ||| S:6243 E:6246 ||| CD
to  ||| S:6246 E:6249 ||| TO
10  ||| S:6249 E:6252 ||| CD
cells  ||| S:6252 E:6258 ||| NNS
on  ||| S:6258 E:6261 ||| IN
a  ||| S:6261 E:6263 ||| DT
flat  ||| S:6263 E:6268 ||| JJ
surface ||| S:6268 E:6275 ||| NN
.  ||| S:6275 E:6277 ||| .
Microfluidics  ||| S:6277 E:6291 ||| NNP
also  ||| S:6291 E:6296 ||| RB
allow  ||| S:6296 E:6302 ||| VB
for  ||| S:6302 E:6306 ||| IN
chemical  ||| S:6306 E:6315 ||| JJ
gradients ||| S:6315 E:6324 ||| NN
,  ||| S:6324 E:6326 ||| ,
the  ||| S:6326 E:6330 ||| DT
continuous  ||| S:6330 E:6341 ||| JJ
flow  ||| S:6341 E:6346 ||| NN
of  ||| S:6346 E:6349 ||| IN
fresh  ||| S:6349 E:6355 ||| JJ
media ||| S:6355 E:6360 ||| NNS
,  ||| S:6360 E:6362 ||| ,
high  ||| S:6362 E:6367 ||| JJ
through  ||| S:6367 E:6375 ||| IN
put  ||| S:6375 E:6379 ||| JJ
testing ||| S:6379 E:6386 ||| NN
,  ||| S:6386 E:6388 ||| ,
and  ||| S:6388 E:6392 ||| CC
direct  ||| S:6392 E:6399 ||| JJ
output  ||| S:6399 E:6406 ||| NN
to  ||| S:6406 E:6409 ||| TO
analytical  ||| S:6409 E:6420 ||| VB
instruments ||| S:6420 E:6431 ||| NNS
.  ||| S:6431 E:6433 ||| .
Many  ||| S:6433 E:6438 ||| JJ
microfluidic  ||| S:6438 E:6451 ||| JJ
systems  ||| S:6451 E:6459 ||| NNS
employ  ||| S:6459 E:6466 ||| VBP
the  ||| S:6466 E:6470 ||| DT
use  ||| S:6470 E:6474 ||| NN
of  ||| S:6474 E:6477 ||| IN
hydrogels  ||| S:6477 E:6487 ||| NN
as  ||| S:6487 E:6490 ||| IN
the  ||| S:6490 E:6494 ||| DT
extracellular  ||| S:6494 E:6508 ||| JJ
matrix  ||| S:6508 E:6515 ||| NNS
( ||| S:6515 E:6516 ||| -LRB-
ECM ||| S:6516 E:6519 ||| NNP
)  ||| S:6519 E:6521 ||| -RRB-
support  ||| S:6521 E:6529 ||| NN
which  ||| S:6529 E:6535 ||| WDT
can  ||| S:6535 E:6539 ||| MD
be  ||| S:6539 E:6542 ||| VB
modulated  ||| S:6542 E:6552 ||| VBN
for  ||| S:6552 E:6556 ||| IN
fiber  ||| S:6556 E:6562 ||| NN
thickness  ||| S:6562 E:6572 ||| NN
and  ||| S:6572 E:6576 ||| CC
pore  ||| S:6576 E:6581 ||| JJ
size  ||| S:6581 E:6586 ||| NN
and  ||| S:6586 E:6590 ||| CC
have  ||| S:6590 E:6595 ||| VBP
been  ||| S:6595 E:6600 ||| VBN
demonstrated  ||| S:6600 E:6613 ||| VBN
to  ||| S:6613 E:6616 ||| TO
allow  ||| S:6616 E:6622 ||| VB
the  ||| S:6622 E:6626 ||| DT
growth  ||| S:6626 E:6633 ||| NN
of  ||| S:6633 E:6636 ||| IN
cancer  ||| S:6636 E:6643 ||| NN
cells ||| S:6643 E:6648 ||| NNS
.  ||| S:6648 E:6650 ||| .
Gel  ||| S:6650 E:6654 ||| JJ
free  ||| S:6654 E:6659 ||| JJ
3D  ||| S:6659 E:6662 ||| CD
cell  ||| S:6662 E:6667 ||| NN
cultures  ||| S:6667 E:6676 ||| NNS
have  ||| S:6676 E:6681 ||| VBP
been  ||| S:6681 E:6686 ||| VBN
developed  ||| S:6686 E:6696 ||| VBN
to  ||| S:6696 E:6699 ||| TO
allow  ||| S:6699 E:6705 ||| VB
cells  ||| S:6705 E:6711 ||| NNS
to  ||| S:6711 E:6714 ||| TO
grow  ||| S:6714 E:6719 ||| VB
in  ||| S:6719 E:6722 ||| IN
either  ||| S:6722 E:6729 ||| RB
a  ||| S:6729 E:6731 ||| DT
cell  ||| S:6731 E:6736 ||| NN
dense  ||| S:6736 E:6742 ||| JJ
environment  ||| S:6742 E:6754 ||| NN
or  ||| S:6754 E:6757 ||| CC
an  ||| S:6757 E:6760 ||| DT
ECM  ||| S:6760 E:6764 ||| NNP
poor  ||| S:6764 E:6769 ||| JJ
environment ||| S:6769 E:6780 ||| NN
.  ||| S:6780 E:6782 ||| .
Although  ||| S:6782 E:6791 ||| IN
these  ||| S:6791 E:6797 ||| DT
devices  ||| S:6797 E:6805 ||| NNS
have  ||| S:6805 E:6810 ||| VBP
proven  ||| S:6810 E:6817 ||| VBN
very  ||| S:6817 E:6822 ||| RB
useful ||| S:6822 E:6828 ||| JJ
,  ||| S:6828 E:6830 ||| ,
there  ||| S:6830 E:6836 ||| EX
are  ||| S:6836 E:6840 ||| VBP
certain  ||| S:6840 E:6848 ||| JJ
disadvantages  ||| S:6848 E:6862 ||| JJ
such  ||| S:6862 E:6867 ||| JJ
as  ||| S:6867 E:6870 ||| IN
cells  ||| S:6870 E:6876 ||| NNS
sticking  ||| S:6876 E:6885 ||| VBG
to  ||| S:6885 E:6888 ||| TO
the  ||| S:6888 E:6892 ||| DT
PDMS  ||| S:6892 E:6897 ||| NNP
surface ||| S:6897 E:6904 ||| NN
,  ||| S:6904 E:6906 ||| ,
small  ||| S:6906 E:6912 ||| JJ
molecules  ||| S:6912 E:6922 ||| JJ
diffusing  ||| S:6922 E:6932 ||| NN
into  ||| S:6932 E:6937 ||| IN
the  ||| S:6937 E:6941 ||| DT
PDMS ||| S:6941 E:6945 ||| NNP
,  ||| S:6945 E:6947 ||| ,
and  ||| S:6947 E:6951 ||| CC
unreacted  ||| S:6951 E:6961 ||| JJ
PDMS  ||| S:6961 E:6966 ||| NN
polymers  ||| S:6966 E:6975 ||| NNS
washing  ||| S:6975 E:6983 ||| VBG
into  ||| S:6983 E:6988 ||| IN
cell  ||| S:6988 E:6993 ||| NN
culture  ||| S:6993 E:7001 ||| NN
media ||| S:7001 E:7006 ||| NNS
The  ||| S:7009 E:7013 ||| DT
use  ||| S:7013 E:7017 ||| NN
of  ||| S:7017 E:7020 ||| IN
3D  ||| S:7020 E:7023 ||| CD
cell  ||| S:7023 E:7028 ||| NN
cultures  ||| S:7028 E:7037 ||| NNS
in  ||| S:7037 E:7040 ||| IN
microfluidic  ||| S:7040 E:7053 ||| JJ
devices  ||| S:7053 E:7061 ||| NNS
has  ||| S:7061 E:7065 ||| VBZ
led  ||| S:7065 E:7069 ||| VBN
to  ||| S:7069 E:7072 ||| TO
a  ||| S:7072 E:7074 ||| DT
field  ||| S:7074 E:7080 ||| NN
of  ||| S:7080 E:7083 ||| IN
study  ||| S:7083 E:7089 ||| NN
called  ||| S:7089 E:7096 ||| VBD
organ-on-a-chip ||| S:7096 E:7111 ||| JJ
.  ||| S:7111 E:7113 ||| .
The  ||| S:7113 E:7117 ||| DT
first  ||| S:7117 E:7123 ||| JJ
report  ||| S:7123 E:7130 ||| NN
of  ||| S:7130 E:7133 ||| IN
these  ||| S:7133 E:7139 ||| DT
types  ||| S:7139 E:7145 ||| NNS
of  ||| S:7145 E:7148 ||| IN
microfluidic  ||| S:7148 E:7161 ||| JJ
cultures  ||| S:7161 E:7170 ||| NNS
was  ||| S:7170 E:7174 ||| VBD
used  ||| S:7174 E:7179 ||| VBN
to  ||| S:7179 E:7182 ||| TO
study  ||| S:7182 E:7188 ||| VB
the  ||| S:7188 E:7192 ||| DT
toxicity  ||| S:7192 E:7201 ||| NN
of  ||| S:7201 E:7204 ||| IN
naphthalene  ||| S:7204 E:7216 ||| JJ
metabolites  ||| S:7216 E:7228 ||| NN
on  ||| S:7228 E:7231 ||| IN
the  ||| S:7231 E:7235 ||| DT
liver  ||| S:7235 E:7241 ||| NN
and  ||| S:7241 E:7245 ||| CC
lung  ||| S:7245 E:7250 ||| NN
( ||| S:7250 E:7251 ||| -LRB-
Viravaidya  ||| S:7251 E:7262 ||| FW
et  ||| S:7262 E:7265 ||| FW
al. ||| S:7265 E:7268 ||| FW
) ||| S:7268 E:7269 ||| -RRB-
.  ||| S:7269 E:7271 ||| .
These  ||| S:7271 E:7277 ||| DT
devices  ||| S:7277 E:7285 ||| NNS
can  ||| S:7285 E:7289 ||| MD
grow  ||| S:7289 E:7294 ||| VB
a  ||| S:7294 E:7296 ||| DT
stripped-down  ||| S:7296 E:7310 ||| JJ
version  ||| S:7310 E:7318 ||| NN
of  ||| S:7318 E:7321 ||| IN
an  ||| S:7321 E:7324 ||| DT
organ-like  ||| S:7324 E:7335 ||| JJ
system  ||| S:7335 E:7342 ||| NN
that  ||| S:7342 E:7347 ||| WDT
can  ||| S:7347 E:7351 ||| MD
be  ||| S:7351 E:7354 ||| VB
used  ||| S:7354 E:7359 ||| VBN
to  ||| S:7359 E:7362 ||| TO
understand  ||| S:7362 E:7373 ||| VB
many  ||| S:7373 E:7378 ||| JJ
biological  ||| S:7378 E:7389 ||| JJ
processes ||| S:7389 E:7398 ||| NNS
.  ||| S:7398 E:7400 ||| .
By  ||| S:7400 E:7403 ||| IN
adding  ||| S:7403 E:7410 ||| VBG
an  ||| S:7410 E:7413 ||| DT
additional  ||| S:7413 E:7424 ||| JJ
dimension ||| S:7424 E:7433 ||| NN
,  ||| S:7433 E:7435 ||| ,
more  ||| S:7435 E:7440 ||| RBR
advanced  ||| S:7440 E:7449 ||| JJ
cell  ||| S:7449 E:7454 ||| NN
architectures  ||| S:7454 E:7468 ||| NNS
can  ||| S:7468 E:7472 ||| MD
be  ||| S:7472 E:7475 ||| VB
achieved ||| S:7475 E:7483 ||| VBN
,  ||| S:7483 E:7485 ||| ,
and  ||| S:7485 E:7489 ||| CC
cell  ||| S:7489 E:7494 ||| NN
behavior  ||| S:7494 E:7503 ||| NN
is  ||| S:7503 E:7506 ||| VBZ
more  ||| S:7506 E:7511 ||| JJR
representative  ||| S:7511 E:7526 ||| NN
of  ||| S:7526 E:7529 ||| IN
"in  ||| S:7529 E:7533 ||| CD
vivo ||| S:7533 E:7537 ||| NN
"  ||| S:7537 E:7539 ||| ''
dynamics ||| S:7539 E:7547 ||| NNS
;  ||| S:7547 E:7549 ||| :
cells  ||| S:7549 E:7555 ||| NNS
can  ||| S:7555 E:7559 ||| MD
engage  ||| S:7559 E:7566 ||| VB
in  ||| S:7566 E:7569 ||| IN
enhanced  ||| S:7569 E:7578 ||| JJ
communication  ||| S:7578 E:7592 ||| NN
with  ||| S:7592 E:7597 ||| IN
neighboring  ||| S:7597 E:7609 ||| JJ
cells  ||| S:7609 E:7615 ||| NNS
and  ||| S:7615 E:7619 ||| CC
cell-extracellular  ||| S:7619 E:7638 ||| JJ
matrix  ||| S:7638 E:7645 ||| JJ
interactions  ||| S:7645 E:7658 ||| NNS
can  ||| S:7658 E:7662 ||| MD
be  ||| S:7662 E:7665 ||| VB
modeled ||| S:7665 E:7672 ||| VBN
.  ||| S:7672 E:7674 ||| .
In  ||| S:7674 E:7677 ||| IN
these  ||| S:7677 E:7683 ||| DT
devices ||| S:7683 E:7690 ||| NNS
,  ||| S:7690 E:7692 ||| ,
chambers  ||| S:7692 E:7701 ||| NNS
or  ||| S:7701 E:7704 ||| CC
collagen  ||| S:7704 E:7713 ||| JJ
layers  ||| S:7713 E:7720 ||| NNS
containing  ||| S:7720 E:7731 ||| VBG
different  ||| S:7731 E:7741 ||| JJ
cell  ||| S:7741 E:7746 ||| NN
types  ||| S:7746 E:7752 ||| NNS
can  ||| S:7752 E:7756 ||| MD
interact  ||| S:7756 E:7765 ||| VB
with  ||| S:7765 E:7770 ||| IN
one  ||| S:7770 E:7774 ||| CD
another  ||| S:7774 E:7782 ||| DT
for  ||| S:7782 E:7786 ||| IN
multiple  ||| S:7786 E:7795 ||| JJ
days  ||| S:7795 E:7800 ||| NNS
while  ||| S:7800 E:7806 ||| IN
various  ||| S:7806 E:7814 ||| JJ
channels  ||| S:7814 E:7823 ||| NNS
deliver  ||| S:7823 E:7831 ||| VBP
nutrients  ||| S:7831 E:7841 ||| VBN
to  ||| S:7841 E:7844 ||| TO
the  ||| S:7844 E:7848 ||| DT
cells ||| S:7848 E:7853 ||| NNS
.  ||| S:7853 E:7855 ||| .
An  ||| S:7855 E:7858 ||| DT
advantage  ||| S:7858 E:7868 ||| NN
of  ||| S:7868 E:7871 ||| IN
these  ||| S:7871 E:7877 ||| DT
devices  ||| S:7877 E:7885 ||| NNS
is  ||| S:7885 E:7888 ||| VBZ
that  ||| S:7888 E:7893 ||| DT
tissue  ||| S:7893 E:7900 ||| NN
function  ||| S:7900 E:7909 ||| NN
can  ||| S:7909 E:7913 ||| MD
be  ||| S:7913 E:7916 ||| VB
characterized  ||| S:7916 E:7930 ||| VBN
and  ||| S:7930 E:7934 ||| CC
observed  ||| S:7934 E:7943 ||| VBD
under  ||| S:7943 E:7949 ||| IN
controlled  ||| S:7949 E:7960 ||| JJ
conditions  ||| S:7960 E:7971 ||| NNS
( ||| S:7971 E:7972 ||| -LRB-
e.g. ||| S:7972 E:7976 ||| NNP
,  ||| S:7976 E:7978 ||| ,
effect  ||| S:7978 E:7985 ||| NN
of  ||| S:7985 E:7988 ||| IN
shear  ||| S:7988 E:7994 ||| JJ
stress  ||| S:7994 E:8001 ||| NN
on  ||| S:8001 E:8004 ||| IN
cells ||| S:8004 E:8009 ||| NNS
,  ||| S:8009 E:8011 ||| ,
effect  ||| S:8011 E:8018 ||| NN
of  ||| S:8018 E:8021 ||| IN
cyclic  ||| S:8021 E:8028 ||| JJ
strain  ||| S:8028 E:8035 ||| NN
or  ||| S:8035 E:8038 ||| CC
other  ||| S:8038 E:8044 ||| JJ
forces ||| S:8044 E:8050 ||| NNS
)  ||| S:8050 E:8052 ||| -RRB-
to  ||| S:8052 E:8055 ||| TO
better  ||| S:8055 E:8062 ||| RB
understand  ||| S:8062 E:8073 ||| VB
the  ||| S:8073 E:8077 ||| DT
overall  ||| S:8077 E:8085 ||| JJ
function  ||| S:8085 E:8094 ||| NN
of  ||| S:8094 E:8097 ||| IN
the  ||| S:8097 E:8101 ||| DT
organ ||| S:8101 E:8106 ||| NN
.  ||| S:8106 E:8108 ||| .
While  ||| S:8108 E:8114 ||| IN
these  ||| S:8114 E:8120 ||| DT
3D  ||| S:8120 E:8123 ||| CD
models  ||| S:8123 E:8130 ||| NNS
ofter  ||| S:8130 E:8136 ||| VBP
better  ||| S:8136 E:8143 ||| JJR
model  ||| S:8143 E:8149 ||| NN
organ  ||| S:8149 E:8155 ||| NN
function  ||| S:8155 E:8164 ||| NN
on  ||| S:8164 E:8167 ||| IN
a  ||| S:8167 E:8169 ||| DT
cellular  ||| S:8169 E:8178 ||| JJ
level  ||| S:8178 E:8184 ||| NN
compared  ||| S:8184 E:8193 ||| VBN
with  ||| S:8193 E:8198 ||| IN
2D  ||| S:8198 E:8201 ||| CD
models ||| S:8201 E:8207 ||| NNS
,  ||| S:8207 E:8209 ||| ,
there  ||| S:8209 E:8215 ||| EX
are  ||| S:8215 E:8219 ||| VBP
still  ||| S:8219 E:8225 ||| RB
challenges ||| S:8225 E:8235 ||| NNS
.  ||| S:8235 E:8237 ||| .
Some  ||| S:8237 E:8242 ||| DT
of  ||| S:8242 E:8245 ||| IN
the  ||| S:8245 E:8249 ||| DT
challenges  ||| S:8249 E:8260 ||| NNS
include ||| S:8260 E:8267 ||| VBP
:  ||| S:8267 E:8269 ||| :
imaging  ||| S:8269 E:8277 ||| NN
of  ||| S:8277 E:8280 ||| IN
the  ||| S:8280 E:8284 ||| DT
cells ||| S:8284 E:8289 ||| NNS
,  ||| S:8289 E:8291 ||| ,
control  ||| S:8291 E:8299 ||| NN
of  ||| S:8299 E:8302 ||| IN
gradients  ||| S:8302 E:8312 ||| NN
in  ||| S:8312 E:8315 ||| IN
static  ||| S:8315 E:8322 ||| JJ
models  ||| S:8322 E:8329 ||| NNS
( ||| S:8329 E:8330 ||| -LRB-
i.e. ||| S:8330 E:8334 ||| FW
,  ||| S:8334 E:8336 ||| ,
without  ||| S:8336 E:8344 ||| IN
a  ||| S:8344 E:8346 ||| DT
perfusion  ||| S:8346 E:8356 ||| JJ
system ||| S:8356 E:8362 ||| NN
) ||| S:8362 E:8363 ||| -RRB-
,  ||| S:8363 E:8365 ||| ,
and  ||| S:8365 E:8369 ||| CC
difficulty  ||| S:8369 E:8380 ||| NN
recreating  ||| S:8380 E:8391 ||| NN
vasculature ||| S:8391 E:8402 ||| NN
.  ||| S:8402 E:8404 ||| .
Despite  ||| S:8404 E:8412 ||| IN
these  ||| S:8412 E:8418 ||| DT
challenges ||| S:8418 E:8428 ||| NNS
,  ||| S:8428 E:8430 ||| ,
3D  ||| S:8430 E:8433 ||| CD
models  ||| S:8433 E:8440 ||| NNS
are  ||| S:8440 E:8444 ||| VBP
still  ||| S:8444 E:8450 ||| RB
used  ||| S:8450 E:8455 ||| VBN
as  ||| S:8455 E:8458 ||| IN
tools  ||| S:8458 E:8464 ||| NNS
for  ||| S:8464 E:8468 ||| IN
studying  ||| S:8468 E:8477 ||| VBG
and  ||| S:8477 E:8481 ||| CC
testing  ||| S:8481 E:8489 ||| NN
drug  ||| S:8489 E:8494 ||| NN
responses  ||| S:8494 E:8504 ||| NNS
in  ||| S:8504 E:8507 ||| IN
pharmacological  ||| S:8507 E:8523 ||| JJ
studies ||| S:8523 E:8530 ||| NNS
.  ||| S:8530 E:8532 ||| .
In  ||| S:8532 E:8535 ||| IN
recent  ||| S:8535 E:8542 ||| JJ
years ||| S:8542 E:8547 ||| NNS
,  ||| S:8547 E:8549 ||| ,
there  ||| S:8549 E:8555 ||| EX
are  ||| S:8555 E:8559 ||| VBP
microfluidic  ||| S:8559 E:8572 ||| JJ
devices  ||| S:8572 E:8580 ||| NNS
reproducing  ||| S:8580 E:8592 ||| VBP
the  ||| S:8592 E:8596 ||| DT
complex  ||| S:8596 E:8604 ||| JJ
"in  ||| S:8604 E:8608 ||| CD
vivo ||| S:8608 E:8612 ||| NN
"  ||| S:8612 E:8614 ||| ``
microvascular  ||| S:8614 E:8628 ||| JJ
network ||| S:8628 E:8635 ||| NN
.  ||| S:8635 E:8637 ||| .
Organs-on-a-chip  ||| S:8637 E:8654 ||| NNS
have  ||| S:8654 E:8659 ||| VBP
also  ||| S:8659 E:8664 ||| RB
been  ||| S:8664 E:8669 ||| VBN
used  ||| S:8669 E:8674 ||| VBN
to  ||| S:8674 E:8677 ||| TO
replicate  ||| S:8677 E:8687 ||| VB
very  ||| S:8687 E:8692 ||| RB
complex  ||| S:8692 E:8700 ||| JJ
systems  ||| S:8700 E:8708 ||| NNS
like  ||| S:8708 E:8713 ||| IN
lung  ||| S:8713 E:8718 ||| NN
epithelial  ||| S:8718 E:8729 ||| NN
cells  ||| S:8729 E:8735 ||| NNS
in  ||| S:8735 E:8738 ||| IN
an  ||| S:8738 E:8741 ||| DT
exposed  ||| S:8741 E:8749 ||| JJ
airway  ||| S:8749 E:8756 ||| NN
and  ||| S:8756 E:8760 ||| CC
provides  ||| S:8760 E:8769 ||| VBZ
valuable  ||| S:8769 E:8778 ||| JJ
insight  ||| S:8778 E:8786 ||| NN
for  ||| S:8786 E:8790 ||| IN
how  ||| S:8790 E:8794 ||| WRB
multicellular  ||| S:8794 E:8808 ||| JJ
systems  ||| S:8808 E:8816 ||| NNS
and  ||| S:8816 E:8820 ||| CC
tissues  ||| S:8820 E:8828 ||| FW
function  ||| S:8828 E:8837 ||| FW
"in  ||| S:8837 E:8841 ||| FW
vivo ||| S:8841 E:8845 ||| FW
. ||| S:8845 E:8846 ||| FW
"  ||| S:8846 E:8848 ||| ''
These  ||| S:8848 E:8854 ||| DT
devices  ||| S:8854 E:8862 ||| NNS
are  ||| S:8862 E:8866 ||| VBP
able  ||| S:8866 E:8871 ||| JJ
to  ||| S:8871 E:8874 ||| TO
create  ||| S:8874 E:8881 ||| VB
a  ||| S:8881 E:8883 ||| DT
physiologically  ||| S:8883 E:8899 ||| JJ
realistic  ||| S:8899 E:8909 ||| JJ
3D  ||| S:8909 E:8912 ||| CD
environment ||| S:8912 E:8923 ||| NN
,  ||| S:8923 E:8925 ||| ,
which  ||| S:8925 E:8931 ||| WDT
is  ||| S:8931 E:8934 ||| VBZ
desirable  ||| S:8934 E:8944 ||| JJ
as  ||| S:8944 E:8947 ||| IN
a  ||| S:8947 E:8949 ||| DT
tool  ||| S:8949 E:8954 ||| NN
for  ||| S:8954 E:8958 ||| IN
drug  ||| S:8958 E:8963 ||| NN
screening ||| S:8963 E:8972 ||| NN
,  ||| S:8972 E:8974 ||| ,
drug  ||| S:8974 E:8979 ||| NN
delivery ||| S:8979 E:8987 ||| NN
,  ||| S:8987 E:8989 ||| ,
cell-cell  ||| S:8989 E:8999 ||| JJ
interactions ||| S:8999 E:9011 ||| NNS
,  ||| S:9011 E:9013 ||| ,
tumor  ||| S:9013 E:9019 ||| FW
metastasis  ||| S:9019 E:9030 ||| FW
etc ||| S:9030 E:9033 ||| FW
.  ||| S:9033 E:9035 ||| .
In  ||| S:9035 E:9038 ||| IN
one  ||| S:9038 E:9042 ||| CD
study ||| S:9042 E:9047 ||| NN
,  ||| S:9047 E:9049 ||| ,
researchers  ||| S:9049 E:9061 ||| NNS
grew  ||| S:9061 E:9066 ||| VBD
tumor  ||| S:9066 E:9072 ||| NN
cells  ||| S:9072 E:9078 ||| NNS
and  ||| S:9078 E:9082 ||| CC
tested  ||| S:9082 E:9089 ||| VBD
the  ||| S:9089 E:9093 ||| DT
drug  ||| S:9093 E:9098 ||| NN
delivery  ||| S:9098 E:9107 ||| NN
of  ||| S:9107 E:9110 ||| IN
cis  ||| S:9110 E:9114 ||| JJ
platin ||| S:9114 E:9120 ||| NN
,  ||| S:9120 E:9122 ||| ,
resveratrol ||| S:9122 E:9133 ||| NN
,  ||| S:9133 E:9135 ||| ,
tirapazamine  ||| S:9135 E:9148 ||| NNS
( ||| S:9148 E:9149 ||| -LRB-
TPZ ||| S:9149 E:9152 ||| NNP
)  ||| S:9152 E:9154 ||| -RRB-
and  ||| S:9154 E:9158 ||| CC
then  ||| S:9158 E:9163 ||| RB
measured  ||| S:9163 E:9172 ||| VBN
the  ||| S:9172 E:9176 ||| DT
effects  ||| S:9176 E:9184 ||| NNS
the  ||| S:9184 E:9188 ||| DT
drugs  ||| S:9188 E:9194 ||| NNS
have  ||| S:9194 E:9199 ||| VBP
on  ||| S:9199 E:9202 ||| IN
cell  ||| S:9202 E:9207 ||| NN
viability ||| S:9207 E:9216 ||| NN
